Two versus three doses of Menjugate in infants from Germany.

Trial Profile

Two versus three doses of Menjugate in infants from Germany.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Hib-DTaP-hepatitis B-poliovirus vaccine; Meningococcal vaccine group C conjugate; Meningococcal vaccine groups A and C polysaccharide
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group C infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Chiron Behring
  • Most Recent Events

    • 27 Jun 2011 New source for the extension trial identified and integrated (European Clinical Trials Database record EudraCT2004-005150-31).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top